Cystoscopic removal of transvaginal mesh: Long‐term outcomes

Abstract

AbstractObjectivesThis study's aim is to evaluate the long‐term quality of life and functional outcomes following cystoscopic excision of stress urinary incontinence (SUI) and pelvic organ prolapse (POP) mesh extruded into the urinary tract in women.Patients and MethodsA retrospective chart review was performed of all cases of cystoscopic removal of extruded mesh at our high‐volume tertiary care centre between April 2013 and August 2021. Postoperative patient‐reported outcomes were collected via questionnaires: Urogenital Distress Inventory Short Form (UDI‐6), EQ‐5D‐5L Visual analogue scale, ICIQ‐Satisfaction (ICIQ‐S) and additional questions regarding postoperative sexual function.ResultsDuring the study period, 27 women with a median age of 61 years (45–87) underwent cystoscopic mesh removal surgery using either Ho‐YAG laser (56%) or bipolar loop resection (44%). The most common presentation of mesh extrusion was recurrent urinary tract infections (67%). Other presenting complaints were pain (41%), urinary urgency ± incontinence (41%) and voiding difficulties (18%). Long‐term follow‐up outcomes from 20 patients (median follow‐up: 24 months) showed that mesh removal was rated successful by 80%, and 100% would choose to have the surgery again if in the same situation. Recurrent SUI was reported by 45% of respondents, and urinary urge incontinence was found in 50%. For patients who answered the sexual function questions, 50% reported improved sexual function postmesh removal (6/12).ConclusionsCystoscopic removal of extruded female SUI and POP mesh is associated with high patient satisfaction and low morbidity in appropriately selected patients at 2‐year median follow‐up. A patient‐centred shared decision‐making process is essential in counselling patients regarding options and expected outcomes following mesh removal surgery.